|
INVITED
LECTURES AT MAJOR INTERNATIONAL MEETINGS & CENTRES
7.1 International
2009
Invited plenary speaker:
Keystone Symposium on Tumor Immunology, January.
2008
Invited speaker:
American Thoracic Society ASM – Postgraduate Course lecturer-
May.
UK House of Commons Subcommittee on Asbestos Diseases – May.
International Mesothelioma Interest Group conference, Amsterdam,
September.
European Respiratory Society ASM, Berlin, October.
2007
Invited Speaker:
Invited
participant. Gordon Conference: New Frontiers in Cancer
Detection & Diagnosis. Dates: 01/21/2007 - 01/26/2007. Location:
Crowne Plaza, Ventura Beach, California.
Thoracic Surgery, Brigham and Women's Hospital, Boston, MA. May.
Pfizer
Pharmaceuticals, New London, CT. May.
NYU,
New York. May.
ATS
Meeting Plenary, San Francisco. May.
Invited
Lecture, Biotherapy Symposium, Hangzhou, China. June.
Invited Lecture, Sekelas Kedokteran, Universitas Indonesia.
July.
Invited Lecture, Asia Pacific Society of Respirology Conference,
Queensland.
2006
Invited Speaker:
“Tumour
antigen cross-presentation”. INSERM - U805, Institut Gustave
Roussy, VILLEJUIF, Paris.
“Tumour antigen cross-presentation - using a tumor as its own
vaccine”.
UCL
(Universite Catholique de Louvain) Brussels campus.
“Mesothelioma” - Service de Pneumologie, Hopital de Brabois, CHU
de Nancy, France.
“Serum
biomarkers of lung malignancy”.
Pneumologie, Rdc Haut CHU BP 217X 38043 Cedex 9 , INSERM U578
GRENOBLE.
“Lung
biomarkers” - Centre for Respiratory Research, Rayne Institute,
University St, London WC1E 6JJ.
“New
mesothelioma biomarkers and therapies” - Royal Marsden Hospital,
London United Kingdom.
“Biomarkers”, “new immunotherapies” and “integrated therapy” -
8th International Conference of the International Mesothelioma
Interest Group.
Sheraton
Chicago Hotel & Towers, Chicago, Illinois USA.
2005
Invited Speaker:
Keystone Tumor Immunology Conference, Colorado, USA. February.
World Lung Cancer Congress, Barcelona, Spain, July.
International Mesothelioma Congress, Antalya, Turkey. December.
2004
Invited Speaker:
IMIG, Italy.
International Congress Immunology (Montreal).
IACLS, Zurich.
World Asbestos Conference, Japan.
2003
Invited Speaker:
World Lung Cancer Conference, Vancouver BC, May. “Mesothelioma –
new approaches”.
Invited Lectures (February, May & August):
San Francisco General Hospital, USA.
Berkeley University, USA.
University of Chile, Santiago, Chile.
UCLA, Los Angeles, USA.
NIH, Bethesda, MD, USA.
RPMS, Imperial College, London, UK.
UCSF, USA.
Sir William Dunn School of Pathology, Oxford University, UK.
John Radcliffe Hospital, Oxford, UK.
Biovex, Oxford, UK.
Corixa Corp, Seattle, USA.
Eli Lilly Corp, Indianapolis, USA.
Pacific Northwest Research Institute, Seattle, USA.
Uni of Washington, Seattle, USA.
University of British Columbia, Vancouver, BC.
2002
Invited Speaker:
Heidelberg Mesothelioma Conference, Heidelberg, May.
“Mesothelioma genetics and therapy”.
2000
Invited Speaker and Workshop Chairman:
Keystone Conference on Tumour and Cellular Immunology, Santa Fe,
January 2000. “Tolerance and anti-tumour immunity”.
Invited Symposium Speaker:
American Thoracic Society International Conference, Toronto, May
2000. “TCR Transgenic cells in lung research”.
Invited Chairman:
ATS Postgraduate Course on Advanced Techniques in Molecular
Biology.
1999
Invited Speaker:
American Thoracic Society International Conference, San Diego,
April 1999. “Advanced Techniques in Molecular Biology and
Immunology”.
1998
Invited Symposium Speaker and Co-Chair:
American Thoracic Society International Conference, Chicago,
USA. “Gene therapy of mesothelioma – immune approaches”.
Invited Speaker:
5th Asia-Pacific Congres of Respirology, Sydney,
Australia. “Basic aspects of lung immunology”.
Invited Lecture:
University of Chicago, Chicago, USA. “Use of TcR transgenics to
analyse anti-tumour immune responses”.
Invited Lecture:
Pittsburgh Cancer Centre, Pittsburgh, USA. “Use of TcR
transgenics to analyse anti-tumour immune responses”.
Invited Lecture:
RPMS, Imperial College, London, United Kingdom. “Use of TcR
transgenics to analyse anti-tumour immune responses”.
1997
Invited Lecture:
Australasian College of Physical Scientists and Engineers in
Medicine, Annual Scientific Meeting, Perth, Australia. “Research
in a teaching hospital”.
Invited Speaker & Co-Chairman:
International Mesothelioma Interest Group Scientific Meeting,
Philadelphia, USA. “Immunological approaches to gene therapy of
mesothelioma”.
Invited Symposia Speaker & Co-Chairman:
World Lung Cancer Conference, Dublin, Ireland. “Gene therapy of
lung malignancies”
1996
Invited Symposium Speaker:
10th International Biotechnology Symposium, Sydney.
“Gene therapy of cancer”.
Invited Speaker:
Asia Pacific Society of Respirology, Beijing. “Immune responses
in the lung”.
Invited Speaker:
Biomedical Research Centre, Vancouver, BC. “Gene transfer and
antisense approaches to cancer”.
1995
Invited Symposium Speaker and Chairman:
International Mesothelioma Conference, Paris, France. September
1995. “Immunology of Mesothelioma” and “Potential for Gene
Therapy of Mesothelioma”.
Invited Lecture:
Gene Therapy Inc., Gathersburg, Maryland, USA. September 1995
“Gene Therapy of Mesothelioma”.
Invited Lecture:
University of Maryland, Maryland, USA. September 1995 “MHC
Molecules and Immune Recognition of Tumours”.
Invited Lecture:
Dept of Oncology, Johns Hopkins Medical School, Baltimore,
Maryland, USA. September 1995.
“Co-stimulation, Immune Recognition and Immune Deviation in
Tumour Immunology”.
Invited Lecture:
National Cancer Institute, Frederick, Maryland, USA. September
1995. “Immune Deviation, Co-stimulation and Antisense Inhibition
in Tumour Immunology”
Invited Symposium Speaker:
Asbestos Medico-Legal Conference, Sydney, Australia, November
1995. “Cytokines and the Molecular Biology of Mesothelioma”.
1994
Invited Symposium Speaker:
International Meeting on Lung Tumours, European School of
Oncology, Sydney, September. “Aetiology and pathogenesis of
Mesothelioma”.
Invited Symposium Speaker:
European Respiratory Society Annual Scientific Meeting, Nice,
France, October. “Basic Biology of Mesothelioma”.
Invited Symposium Speaker:
World Congress on Lung Cancer, Colorado Springs, USA. “Early
Staging of Mesothelioma and Clinical Symptoms in the Staging of
Mesothelioma”.
1993
Invited Symposium Lecture:
International Congress on the Regulation of Leukocyte Production
and Immune Function, Society for Leukocyte Biology and
Australian Society for Immunology, December 1993. “Immunobiology
of pulmonary tumours”.
1992
Invited Lecture:
London Chest Hospital, UK. “Mesothelioma – current concepts.”
Invited Lectures:
St. Mary’s Hospital, UK “T cells and the human lung” (October
1992) “Immunobiology of asbestos-induced cancer” (October 1992);
Granulomatous Lung Disease Seminar (November 1992).
Invited Lecture:
National Cancer Institute, NIH, USA “Antisense oligonucleotide
strategies in evaluating autocrine growth factors”.
Invited Lecture:
The Blood Center, Milwaukee, USA. “Lung T cell clones”.
Invited Lectures:
Departments of Immunopathology and Respiratory Medicine,
Massachusetts General Hospital, Boston, USA. “Malignant
mesothelioma” and “Human lung T cell clones and sarcoidosis”.
Invited Lecture:
Mt. Sinai Medical Center, New York, USA. “Current concepts of
mesothelioma”.
Invited Lecture:
New York University Medical Center, Bellevue Hospital, New York,
USA. “Mesothelioma”
Invited Lecture:
St.
Bartholomew’s Hospital, London, United Kingdom. “Current
concepts of mesothelioma”.
Invited Lectures:
National Heart and Lung Institute, Brompton Hospital, London,
United Kingdom. “New approaches to the therapy of mesothelioma”
and “The immunobiology of asbestos-induced cancer”.
Invited Lecture:
Whittington Hospital, London, United Kingdom. “Biology and
therapy of solid human tumours”.
1991
Invited Speaker:
International Conference on Mesothelioma, Paris, 1991.
“Scientific basis of the immunotherapy of malignant
mesothelioma”.
Symposium Chairman:
International Conference on Mesothelioma, Paris, 1991. “Biology
and Mesothelioma”
Invited Speaker:
World Lung Cancer Conference, IUSLC, 1991. “Malignant
mesothelioma: Development of new therapeutic strategies”.
Invited Chairman:
World Lung Cancer Conference, IUSLC, 1991. Mesothelioma
symposium.
1990
Invited Lecture:
Symposium on Health Effects of Grain and Other Organic Dusts,
Perth, March 1990. “Cells, cytokines and organic dust exposure”.
Invited Lecture:
International Conference on the Immunotherapy of Melanoma and
other Cancers, Newcastle, September 1990. “Interferon and
interleukin‑2/LAK cell therapy in mesothelioma”.
1989
Invited Lecture:
Brompton Hospital, London 1989. “Malignant mesothelioma –
oncogenes, growth regulation and immunological features”.
Invited Lecture:
Hopital Bichat, Paris, 1989. “Immunotherapy of malignant
mesothelioma”.
1987
Invited
Lecture:
National Cancer Institute, Washington, DC, May 1987. “NK cells
in the human lung”.
Invited Speaker:
Cardiothoracic Unit, Brompton Hospital, London, England. May,
1987. “Mechanism Underlying Epithelial Cell Damage in Human
Asthma”.
1986
Invited Speaker:
Cardiothoracic Unit, Brompton Hospital, London, England, May,
1986. “BAL studies in Interstitial Lung Diseases”.
Invited Presentation:
Aspen Lung Conference, Aspen, Colorado, June 1986.
“Interleukin‑2, natural killer cells and lung cancer.”
1985
Symposium Co-Chairman:
World
Congress on Diseases of the Chest, August, 1985.
“Bronchoalveolar Lavage in Interstitial Lung Disease.”
Invited Speaker:
World
Congress on Diseases of the Chest, August, 1985. “Use of
bronchoalveolar lavage in evaluating asbestosis and pulmonary
connective tissue diseases”
Invited Speaker:
World
Congress on Diseases of the Chest, August, 1985. Cell Biology
Symposium “Lymphocyte‑Macrophage Interactions”.
1984
Invited Lecture:
Tufts
New England Medical Centre, Boston, USA. January 1984.
“Pulmonary NK cells and their regulation by interleukin‑2 and
gamma‑interferon”.
7.2 National
2008
Invited Lecture:
Presidential Award Lecture, TSANZ, Melbourne, March.
2007
Invited
presentation:
Biomarkers for
Malignant Mesothelioma TSANZ 2007 ASM, March, New Zealand.
2006
Invited speaker:
Thoracic Society of Australia and New Zealand Annual Scientific
Meeting, Canberra
Advanced Trainee Workshop “A balanced life as a doctor”.
ALF Lung Cancer Symposium “Mesothelioma advances”.
SIG Symposium “Biomarkers for mesothelioma”.
Royal Melbourne
Hospital, Melbourne. “Mesothelioma and biomarkers” and “Medical
response to the Indian Ocean Tsunami in Aceh”.
Peter McCallum
Cancer Centre, Melbourne.
“Tumour antigen cross-presentation – biology and significance”
and “The
Indian Ocean Tsunami in Aceh”.
2002
Invited speaker:
Thoracic Society of Australia and New Zealand, Cairns, March.
“Biology and Therapy of Mesothelioma”.
Invited speaker:
Dust
Diseases Board of NSW. Sydney, June. “Biology and Gene Therapy
of Mesothelioma”.
Invited speaker:
Princess Alexandra Hospital, Brisbane. March. “Tumour antigen
cross-presentation”.
2001
Invited Speaker:
Australasian Gene Therapy Society Annual Meeting, Sydney.
“Vaccinia-IL2 use in animal models and human trials”.
Invited Speaker:
Australasian Society for Immunology, Tumor Immunology Workshop.
“Transfection-transgenic analysis of CD40 interactions”.
1999
Invited Speaker:
Australasian Pharmaceutical Sciences Association Meeting. “Gene
Therapy of Cancer”.
1998
Invited Speaker:
John Curtin School of Medical Research, Autoimmunity Workshop,
Canberra, Australia, December, 1998. “Autoimmunity and tumour
immunology”.
Invited Symposium Speaker:
TSANZ Annual Scientific Meeting, Adelaide, Australia, April,
1998. “Gene therapy for lung cancer”.
1997
Invited Speaker:
Australian College of Physical Scientists and Engineers in
Medicine, Sir Charles Gairdner Hospital, Western Australia,
August, 1997. “The role of medical research in major teaching
hospitals”.
Invited Speaker:
Australian Tumour Immunology Workshop, Perth, Australia,
December, 1998. “Immunotherapy approaches to mesothelioma”.
1996
Invited Speaker:
Australian Tumour Immunology Workshop, Daydream Island,
Queensland, December 1996. “Gene transfer approaches in cancer”.
1995
Invited Speaker:
Australian Society for Immunology Annual Scientific Meeting,
Gold Coast, Queensland, December 1995. “B7 transfection and
immune anti-tumour responses”.
1994
Invited Lecture:
University of Sydney, June 1995. “Lung immunology and molecular
biology”.
Invited Lecture:
Thoracic Society of Australia & New Zealand – NSW Branch, June
1995. “The molecular immunology of lung disease”.
1993
Invited Plenary Speaker:
Thoracic Society of Australia and New Zealand, Annual Scientific
Meeting, May 1993. “Current Concepts in Lung Immunology”.
Invited Speaker (breakfast session):
Thoracic Society of Australia and New Zealand, Annual Scientific
Meeting, May 1993. “Pulmonary sarcoidosis”.
Invited Symposium Chairman and Speaker:
Clinical Oncology Society of Australia, Annual Scientific
Meeting, November 1993. “Novel Gene transfer and cytokine
approaches in pulmonary malignancy” and “Novel approaches to
cancer”.
1992
Invited Symposium Chairman:
Thoracic Society of Australia and New Zealand, Annual Scientific
Meeting, April 1992. “Airway Inflammation”
1991
Invited Symposium Speaker:
Thoracic Society of Australia and New Zealand, Advanced Course,
November 1991. ‘Molecular Biology’
Invited Symposium Chairman:
Australian Society for Immunology, Annual Scientific Meeting,
December 1991. ‘Tumour Immunology’
Invited Workshop Chairman:
Australian Society for Immunology, Annual Scientific Meeting,
December 1991. ‘Tumour Immunology’
1990
Invited Chairmanship:
Thoracic Society of Australia Young Investigator Award Session,
April 1990.
Invited Lecture:
Recent Advances in Lung Cancer: Clinical Oncology Society of
Australia/Thoracic Society of Australia Joint Symposium, April
1990. “Mesothelioma – from laboratory to bedside”.
Invited Lecture:
Royal Prince Alfred Hospital, Sydney, New South Wales, August
1990. “Current concepts of mesothelioma”.
Invited Lecture:
National Scientific Meeting, Australian Institute of Medical
Laboratory Scientists, September 1990, Perth. “Cytokines”.
1989
Invited Lecture:
Royal Adelaide Hospital, December 1989. “Pulmonary Sarcoidosis:
current concepts”.
1988
Invited Lecture:
The Australian Society for Medical Research: Symposium on Lung
Cancer, 1988. “An Overview of Pulmonary Tumors: Immunological
Aspects”.
Invited Lecture:
Australian Cytokine Research Association, Sydney, 1988.
“Interleukin‑2”.
Invited Lecture:
Society of Hospital Pharmacists, Annual Meeting, 1988. “The
Immune System” and “Drugs and the Immune System”.
1987
Invited Participant:
National Working Party on Immunotherapy and Cancer, 1987.
Invited Lecture:
International Interest Group Biennial Conference, Perth Dec
2002. “Mesothelin as a novel serum marker for mesothelioma”.
Invited Lecture:
Advanced Technologies in Cancer – from Gene Chips to Gene
Therapy Perth Dec 2002. “The scientific basis for immunogene
therapy”.
Invited Lecture:
Thoracic Society of Australia, Annual Scientific Meeting, June
1987. “The Cell Biology of Human Lung Cancer”.
Invited Chairmanship:
Thoracic Society of Australia, Annual Scientific Meeting, June
1987. “Lung Cell Biology Poster Symposium”.
Invited Chairmanship:
Thoracic Society of Australia Cell Biology Symposium, 1987.
“Current Concepts of Lung Cell Biology”.
1986
Session Co‑Chairman:
Thoracic Society of Australia, Annual Scientific Meeting, June,
1986. “Bronchoalveolar Lavage”.
Chairman:
Thoracic Society of Australia, Annual Scientific Meeting, Cell
Biology Symposium, June, 1986.
Invited Lecture:
Australian Medical Laboratory Technology Society, Annual
Scientific Meeting, Oct, 1986. “Interleukin‑2”.
1985
Invited Lecture:
Walter
and Eliza Hall Institute of Medical Research, Melbourne, July
1985. “Immunological processes in the normal and diseased human
lung”.
Invited Lecture:
John
Curtin School of Medical Research, Canberra, July 1985. “Methods
of evaluating pulmonary inflammation, anti-tumour activity and
protease activity in the normal and diseased human lung”.
Invited Speaker:
National Symposium on Gamma Interferon, Clinical
Oncology Society of Australia Annual Scientific Meeting,
November, 1985. “Gamma Interferon – Biological Role and
Potential Clinical Uses.”
Invited Speaker:
National Bronchoscopy Symposium, Thoracic Society of
Australia, November, 1985. “Clinical Experience with
Bronchoalveolar Lavage”.
1984
Invited Speaker:
Royal College of Pathologists of Australasia Annual
Scientific Meeting, October 1984. “New Methods of Evaluating
Patients with Interstitial Lung Disease”.
Symposium Co-Chairman:
Australian Society for Immunology, Annual Meeting, December
1984. “Lymphokines”.
7.3 Major State Conferences
1995
Invited Lecture:
Cancer Research Association of Western Australia Annual
Scientific Meeting, September 1995. “Practical aspects and
ethics of gene therapy”.
Plus, since 1995, numerous contributions to local conferences,
seminars, clinical meetings, tutorials and small conferences
that are too numerous to list.
1993
Invited Speaker:
Thoracic Society of Australia and New Zealand (WA
Branch) Annual Scientific Meeting, Club Capricorn, March 1993.
“Antioncogenes and mesothelioma”.
Invited Speaker:
KEMH Postgraduate Symposium, October 1993. “Teaching
communication skills in a
clinical context”.
Invited Speaker:
RACGP Postgraduate Symposium, November 1993. “Managing the
difficult asthmatic”.
1991
Invited Lecture:
Royal Australasian College of Physicians (WA Branch), March
1991. “Recent Advances in the Therapy of Human Cancer – Use of
Cytokines and Lymphocytes”.
Invited Speaker:
Cancer Research Association of WA/Thoracic Society of Australia
and New Zealand Joint Symposium on Lung Cancer and Mesothelioma.
Perth. November 1991.
1990
Invited Lecture:
Thoracic Society of Australia: WA Branch Annual Scientific
Meeting, March 1990. “Proteases and epithelial cell damage”.
Invited Chairman:
Combined Biological Sciences Meeting; session on cell biology,
Perth, September 1990.
Invited Lecture:
Australian Association of Clinical Biochemists Scientific
Meeting. ‘Cytokines and Lung Disease’, November 1990.
1989
Invited Lecture:
Thoracic Society of Australia: WA Branch, Annual Scientific
Meeting, May 1989. “Malignant mesothelioma: prospects for future
therapy”.
Invited Lecture:
Cancer Research Association of WA, Annual Scientific Meeting,
1989. “Cell biology and immunology of human malignant
mesothelioma”.
1987
Invited Chairman:
Australian Society of Medical Research. Symposium on Allergy
and Asthma, October 1987.
Invited Chairman:
Cancer Research Association of W.A. Annual Scientific Meeting,
1987.
Return to Resume |
